SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 17, 2003
BioSpecifics Technologies Corp.
(Exact name of registrant as specified in its charter)
Delaware File No. 0-19879 11-3054851
(State of incorporation) (Commission File Number) (IRS Employer
Identification No.)
35 Wilbur Street, Lynbrook, New York 11563
(Address of principal executive offices) (zip code)
Registrant's telephone number, including area code: (516) 593-7000
Item 8. Change in Fiscal Year
On March 17, 2003, the Board of Directors of BioSpecifics Technologies Corp.
(the "Corporation") authorized changing the Corporation's fiscal year end from
January 31 to a calendar year end, or December 31.
The Corporation's final report using the fiscal year ended January 31 will be on
Form 10-KSB for the fiscal year ended January 31, 2003.
The change becomes effective for the fiscal year ended December 31, 2003, and
the Corporation's first report using the new fiscal year will be on Form 10-QSB
for the three months ended March 31, 2003.
-2-
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
BIOSPECIFICS TECHNOLOGIES CORP.
Dated: April 1, 2003 By: /s/ Albert Horcher
------------------------------------
Name: Albert Horcher
Title: Principal Accounting Officer
-3-